Correlates of benefit from neoadjuvant chemotherapy before radiotherapy in non-small cell lung cancer: A meta-analytical approach with meta-regression analysis

Journal of B.U.ON.

Volumn 15, Issue 1, 2010, Pages 43-50

  Bozcuk, Hakan ^a   Artac, M ^b   Ozdogan, M ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

^b SELCUK UNIVERSITY   (Turkey)

Author keywords

Chemotherapy; Meta analysis; Meta regression; Neoadjuvant; Non small cell lung cancer; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; LOMUSTINE; METHOTREXATE; MITOMYCIN; VINDESINE;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; DEATH; HUMAN; LUNG NON SMALL CELL CANCER; META ANALYSIS; MULTIPLE CYCLE TREATMENT; RISK ASSESSMENT; RISK REDUCTION; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77950977590     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997; 111: 1710-1717.
2. Pritchard RS, Anthony SP. Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable, non-small-cell lung cancer. A meta-analysis. Ann Intern Med 1996; 125: 723-729. (Pubitemid 126450359)
3. LeChevalier T, Arriagada R, Quoix E et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients. J Natl Cancer Inst 1991; 83: 417-423.
4. Roth JA, Fossella F, Komaki R et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. J Natl Cancer Inst 1994; 86: 673-680. (Pubitemid 24983600)
5. Berghmans T, Paesmans M, Meert AP et al. Survival improvement in resectable non-small cell lung cancer with (neo) adjuvant chemotherapy: Results of a meta-analysis of the literature. Lung Cancer 2005; 49: 13-23.
6. Non-small-cell lung cancer collaborative group. Chemotherapy in non-small cell lung cancer. A meta-analysis using updated data on individual patients from 52 randomized clinical trials. BMJ 1995; 311: 899-909.
7. Rowell NP, O'Rourke NP. Concurrent chemoradiotherapy in non-small cell lung cancer (Review). Cochrane Database of Systematic Reviews 2004. Art. No.: CD002140.DOI: 10.1002/14651858.CD002140.pub2.
8. Blackstock WA, Govindan R. Definitive chemoradiation for the treatment of locally advanced non-small cell lung cancer. J Clin Oncol 2007; 25: 4146-4152. (Pubitemid 47492959)
9. Saynak M, Aksu G, Fayda M et al. The results of concomitant and sequential chemoradiotherapy with cisplatin and etoposide in patients with locally advanced non-small cell lung cancer. JBUON 2005; 10: 213-218. (Pubitemid 41320562)
10. Langer CJ, Moughan J, Movsas B et al. Patterns of care survey (PCS) in lung cancer: how well does current U.S. practice with chemotherapy in the non-metastatic setting follow the literature? Lung Cancer 2005; 48: 93-102.
11. NCCN Clinical Practice Guidelines in Oncology. Non-Small Cell Lung Cancer v.2.2008, at http://www.nccn.org/professionals/physician-gls/PDF/nscl.pdf
12. Parmar MKB, Machin D. (Eds) Survival Analysis: Practical Approach. Chicester: Wiley, 1995.
13. Sharma S, Sharma R, Bhowmik KT. Sequential chemoradiotherapy versus radiotherapy in the management of locally advanced non-small-cell lung cancer. Adv Ther 2003; 20: 14-19. (Pubitemid 36554436)
14. Van Houtte P, Klastersky J, Renaud A et al. Induction chemotherapy with cisplatin, etoposide and vindesine before radiation therapy for non-small-cell lung cancer. A randomized study. Antibiot Chemother 1988; 41: 131-137.
15. Jadad AR, Moore RA, Carroll D et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 1996; 17: 1-12.
16. Thompson SG, Higgins JPT. Can meta-analysis help target interventions at individuals most likely to benefit? Lancet 2005; 365: 341-346.
17. Hintze J, 2004. NCSS and PASS. Number Cruncher Statistical Systems. Kaysville, Utah, www.ncss.com.
18. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomized controlled trials: the QUOROM statement. Lancet 1999; 354: 1896-1900.
19. Cullen MH, Billingham LJ, Woodroffe CM et al. Mitomycin, ifosfamide and cisplatin in unresectable non-small cell lung cancer: effects on survival and quality of life. J Clin Oncol 1999; 17: 3188-3194.
20. Crino L, Latini P, Meacci M et al. Induction chemotherapy plus high-dose radiotherapy versus radiotherapy alone in locally advanced unresectable non-small cell lung cancer. Ann Oncol 1993; 4: 847-851.
21. Brodin O, Nou E, Mercke C et al. Comparison of induction chemotherapy before radiotherapy with radiotherapy only in patients with locally advanced squamous cell carcinoma of the lung. Eur J Cancer 1996; 32A: 1893-1900. (Pubitemid 26361681)
22. Dillman RO, Herndon J, Seagren SL, Eaton WL Jr, Green MR. Improved survival in stage 3 non-small-cell lung cancer seven-year follow-up of Cancer and Leukemia Group B (CALGB) 8433 trial. J Natl Cancer Inst 1996; 88: 120-125. (Pubitemid 26302034)
23. Kim TY, Yang SH, Lee SH et al. A phase 3 randomized trial of combined chemoradiotherapy versus radiotherapy alone in locally advanced non-small cell lung cancer. Am J Clin Oncol 2002; 25: 238-243. (Pubitemid 34602543)
24. Wolf M, Hans K, Becker H et al. Radiotherapy alone versus chemotherapy with ifosfamide / vindesine followed by radiotherapy in unresectable non-small cell lung cancer. Semin Oncol 1994; 21 (3 Suppl 4): 42-47. (Pubitemid 24191607)
25. Mattson KV, Abratt RP, ten Velde GV, Krofta K. Docetaxel as neoadjuvant therapy for radically treatable stage 3 non-small cell lung cancer: a multinational randomized phase 3 study. Ann Oncol 2003; 14: 116-122.
26. Sause WT, Scott C, Taylor S et al. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary results of a phase 3 trial in regionally advanced, unresectable non-small cell lung cancer. J Natl Cancer Inst 1995; 87: 198-205.
27. Morton RF, Jett JR, McGinnis WL et al. Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer. A randomized, phase 3 trial. Ann Intern Med 1991; 115: 681-686.
28. Gregor A, McBeth FR, Paul JR, Cram L, Hansen HH. Radical radiotherapy and chemotherapy in localized inoperable non-small-cell lung cancer: a randomized trial. J Natl Cancer Inst 1993; 85: 997-999. (Pubitemid 23177587)
29. Planting A, Helle P, Drings P et al. A randomized study of high-dose split course radiotherapy preceded by high-dose chemotherapy versus high dose radiotherapy only in locally advanced non-small-cell lung cancer. Ann Oncol 1996; 7: 139-144. (Pubitemid 26094877)
30. Mattson K, Holsti LR, Holsti P et al. Inoperable non-small cell lung cancer: radiation with or without chemotherapy. Eur J Cancer Clin Oncol 1988; 24: 477-482. (Pubitemid 18071280)
31. Komaki R, Scott CB, Sause WT et al. Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer failure patterns by cell type in RTOG 88-08/ ECOG 4588. Int J Radiat Oncol Biol Phys 1997; 39: 537-543. (Pubitemid 27441416)
32. Marino P, Preatoni A, Cantoni A. Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages 3A and 3B non-small cell lung cancer. A meta-analysis. Cancer 1995: 76: 593-601.
33. Auperin A, Le Pechoux C, Pignon JP et al. Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC): A meta-analysis of individual data from 1764 patients. Ann Oncol 2006; 17: 473-483. (Pubitemid 43329586)
34. Winton T, Livingston R Johnson D et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 2005; 352: 2589-2597. (Pubitemid 41007845)
35. Gandara DR, Chansky K, Albain KS et al. Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non-small-cell lung cancer: phase II Southwest Oncology Group Study S9504. J Clin Oncol 2003; 21: 2004-2010. (Pubitemid 46606390)
36. Glasziou P, Irwig L, Bain C, Colditz G (Eds). Systematic reviews in health care. A Practical Guide. Cambridge: Cambridge University Press, 2001.